MeSH tree: E05.318.740
The prevalence of health care-associated infections was lower in 2023 than in 2015 in the United States, according to a study published in the New England Journal of Medicine.
5 hours ago
0
3
For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration ...
Jul 16, 2026
0
5
Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce quality of life and, in some cases, compromise the continuation of ...
Jul 11, 2026
0
5
An E. coli outbreak linked to frozen blueberries has sickened 12 people, four of them seriously enough to require hospital care, federal health officials say.
Jul 8, 2026
0
4
Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung ...
Jul 7, 2026
0
6
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
Jul 7, 2026
0
5
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
3
Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already ...
Jul 5, 2026
0
14
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...
Jul 2, 2026
0
3
A new international expert consensus statement published in The Lancet Respiratory Medicine provides guidance for doctors on how to identify, monitor and treat a serious lung complication that affects many people living with ...
Jul 2, 2026
0
2
